AI in Genomics Market Size Expected to Reach $9,859.7 Million by 2031 | Freenome holdings, Thermo fisher scientific

PORTLAND, IL, UNITED STATES, June 20, 2025 /EINPresswire.com/ -- According to a new report published by Allied Market Research, titled, “AI in Genomics Market” was valued at $346.3 million in 2021, and is projected to reach $9,859.7 million by 2031, registering a CAGR of 40.6% from 2022 to 2031.

Genomics is the branch of molecular biology that deals with the study of the entire genetic material of an organism, including its DNA sequence, gene structure, function, and organization. It involves the use of advanced technologies and computational tools to analyze and interpret genomic data. Artificial Intelligence (AI) is a branch of computer science that focuses on developing computer systems to perform tasks that typically require human intelligence, such as recognizing speech, making decisions, and learning from experience. AI systems are designed to mimic human cognitive functions such as perception, reasoning, and learning.

Download Research Report Sample & TOC : https://www.alliedmarketresearch.com/request-sample/11921

The rise in applications of AI in drug discovery and development coupled with the advancements in artificial intelligence technology drive the growth of the global AI in genomics market. However, limited availability of skilled professionals and data quality issues restrict the market growth.

Few AI in Genomics Market Trends and applications include gene sequencing, gene expression analysis, and drug discovery. For instance, AI algorithms are being used to improve the accuracy and speed of DNA sequencing. Deep learning algorithms can identify and correct errors in DNA sequences and predict missing parts of the genome. Furthermore, AI algorithms can analyze large-scale gene expression data to identify patterns and predict gene function. This can help researchers understand how genes are regulated and how they contribute to diseases thereby driving the AI in Genomics Market growth.

Competitive analysis offering profiles of top players

Competitive analysis and profiles of the major key players that operate in the AI in genomics market share are Microsoft, IBM, NVIDIA Corporation, Deep Genomics, DATA4CURE, INC, Freenome holdings, Inc, Thermo fisher scientific, Illumina, Inc., Sophia Genetics, and BenevolentAI. are provided in the report. Major players have adopted acquisition, and product launch as key developmental strategies to improve the product portfolio of the invisible orthodontics market.

Futuristic trends in the industry:

Precision Medicine Revolution

AI models are enabling hyper-personalized treatments by decoding individual genomic data at massive scale.

Future: Predictive genomics—foreseeing diseases years before symptoms through AI pattern recognition.

2. AI-Driven Drug Discovery
Genomics + AI is radically reducing drug discovery timelines.

Future: Full in-silico clinical trials using AI-simulated genomes before human trials even begin.

3. Multi-omics Integration
AI will increasingly integrate genomics with proteomics, transcriptomics, metabolomics for a 360° biological view.

Future: Holistic disease modeling for chronic and rare diseases.

4. Federated Learning for Genomics
Data privacy remains a big barrier; federated learning (AI models training across decentralized genomic data) is becoming crucial.

Future: Global genome analysis without cross-border data sharing risks.

Procure Complete Report @ https://www.alliedmarketresearch.com/purchase-enquiry/11921

Industry highlights

In October 2020, NVIDIA announced a partnership with GSK and its AI group, which is applying computation to the drug and vaccine discovery process.
In March 2022, IBM and Genomics England announced a strategic partnership. Genomics England provides researchers access to genomic datasets to enable scientific discovery. The partnership allows IBM to support the rapid expansion of Genomic England by enabling the consumption of cloud services through its AI capabilities

Some Examples of Acquisition In The Artificial Intelligence in Genomics Market

In June 2020, Illumina Inc announced the acquisition of BlueBee, a cloud-based software company that provides genomics analysis solutions for research and clinical customers

AI in Genomics Market Report Highlights:

By Technology

Machine Learning
Computer Vision

By Offering

Hardware
Software
Services

By Application

Drug Discovery and Development
Precision Medicine
Diagnostics
Others

By End User

Pharmaceutical and Biotech Companies
Healthcare Providers
Research Centers

Inquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/A11556

Key Findings of The Study

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ai in genomics market analysis from 2021 to 2031 to identify the prevailing ai in genomics market opportunity.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the ai in genomics industry segmentation assists to determine the prevailing market opportunities.

About Us:

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides end-to-end solutions along with information, education, advocacy, and networking resources to SMEs and early-stage start-ups to bring excellence to their processes. In addition, we offer a nurturing environment required to develop and grow businesses, including business planning; virtual support; market intelligence; acquiring resources; and getting direct access to finance, suppliers, and other experts to boost the growth of businesses and entrepreneurs.

Our bundled and hassle-free business support systems are customized to meet the needs of SME consultants and industry leaders. Moreover, our large network of skilled consultants and experts help start-ups get the business on a roll.

David Correa
Allied Market Research
+ 1800-792-5285
email us here
Visit us on social media:
LinkedIn
Facebook
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.